Neural mechanisms of delirium: Current hypotheses and evolving concepts

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 6, 1999, Pages

  Flacker, Jonathan M ^a,b   Lipsitz, Lewis A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b RESEARCH AND TRAINING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYTOKINE; DOPAMINE; SEROTONIN;

AGED; BRAIN DISEASE; DELIRIUM; HUMAN; HYPOTHESIS; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLICATION; REFERENCE VALUE; REVIEW; SEROTONIN BLOOD LEVEL;

EID: 0033030191     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.6.B239     Document Type: Review

References (128)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: Author; 1994.
2. Naughton BJ, Moran MB, Kadah H, Hemen-Ackah Y, Longano J. Delirium and other cognitive impairments in older adults in an emergency department. Ann Emerg Med. 1995;25:751-755.
3. Gustafson Y, Brannstrom B, Norberg A, Bucht G, Winblad B. Under diagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc. 1991;9:760-765.
4. Levkoff SE, Evans EA, Liptzin B, et al. Delirium: The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med. 1992;152:334-340.
5. Thomas R, Cameron D, Fahs M. A prospective study of delirium and prolonged hospital stay. Arch Gen Psychiatr. 1988;45:937-940.
6. Rogers MP, Liang MH, Daltroy LH, et al. Delirium after elective orthopedic surgery: risk factors and natural history. Int J Psychiatry Med. 1989;19:109-121.
7. Francis J, Kapoor W. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc. 1992;40:601-602.
8. Murray AM, Levkoff SE, Wetle T, et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol. 1993;48:M181-M186.
9. Williams MA, Campbell EB, Raynor WJ, Musholt, MA, Mlynarczyk SM, Crane LF. Predictors of acute confusional states in hospitalized elderly patients. Res Nurs Health. 1985;8:31-40.
10. Gustafson Y, Bergrren D, Brannstrom B, et al. Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc. 1988;36:525-530.
11. Rockwood K. Acute confusion in elderly medical patients. J Am Geriatr Soc. 1989;37:150-154.
12. Francis J, Kapoor W. A prospective study of delirium in hospitalized elderly. JAMA. 1990;263:1097-1101.
13. Schor JD, Levkoff SE, Lipsitz LA, et al. Risk factors for delirium in hospitalized elderly. JAMA. 1992;267:827-831.
14. Williams-Russo P, Urquhart B, Sharrock N, Charlson M. Post-operative delirium: predictors and prognosis in elderly orthopedic patients. J Am Geriatr Soc. 1992;40:759-767.
15. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly based on admission characteristics. Ann Intern Med. 1993;119:474-481.
16. Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 1994;271:134-139.
17. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275:852-857.
18. Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994;97:278-288.
19. Adams RD, Victor M, Ropper AH. The neurology of aging. In: Adams RD, Victor M, Ropper AH, eds. Principles of Neurology. New York, NY: McGraw-Hill; 1997:608-620.
20. Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging. 1987;8:521-545.
21. Rupert MP, Eisdorfer C, Lowenstein DA. Normal aging: changes in sensory/perceptual and cognitive abilities. In: Sadavoy J, Lazarus LW, Jarvik LF, Grossberg GT, eds. Comprehensive Review of Geriatric Psychiatry -II. Washington, DC: American Psychiatric Press; 1996:113-134.
22. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cog. 1995;28:240-258.
23. Lipowski Z. Delirium in the elderly patient. N Engl J Med. 1989;320: 578-582.
24. Hall R, Popkin M, McHenry L. Angel's trumpet psychosis: a central nervous system anticholinergic syndrome. Am J Psychiatr. 1977;134: 312-314.
25. Granacher R, Baldessarini R, Messner E. Physostigmine treatment of delirium induced by anticholinergics. Am Fam Physician. 1976;13:99-103.
26. Trzepacz PT, Leavitt M, Ciongoli K. An animal model for delirium. Psychosomatics. 1992;33:404-415.
27. Itil T, Fink M. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations. J Nerv Ment Dis. 1966;143:492-507.
28. Muller W, Stoll L, Schubert T, Gelbman, C. Central cholinergic functioning and aging. Acta Psychiat Scand. 1991;366:(Suppl)34-39.
29. Tune L, Coyle JT. Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics. Psychopharmachology. 1981;75:9-15.
30. Golinger RC, Peet T, Tune LE. Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatr. 1987;144:1218-1220.
31. Tune LE, Damlouji NF, Holland A, Gardner TJ, Folstein MF, Coyle JT. Association of postoperative delirium with raised serum levels of anti-cholinergic drugs. Lancet. 1981;2:651-652.
32. Mondimore FM, Damlouji N, Folstein MF, Tune L. Post-ECT confusional states associated with elevated serum anticholinergic activity. Am J Psychiatr. 1983;140:930-931.
33. Mach JR, Dysken MW, Kuskowski M, Richelson E, Holden L, Jilk KM. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc. 1995;43:491-495.
34. Flacker JM, Cummings V, Mach JR, Bettin K, Keily DK, Wei, J. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatr. 1998;6:31-41.
35. Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means of assessing risk of delirium. Am J Psychiatr 1992;149;1393-1394.
36. Tune L. Anticholinergic effect of drugs for the elderly. (Letter.) Am J Psychiatr. 1993;150:1757.
37. Coffman J, Dilsaver S. Cholinergic mechanisms in delirium. (Letter.) Am J Psychiatr. 1988;145:382-383.
38. Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP. Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci. 1990;240:28-33.
39. Flacker JM, Lipsitz LA. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol Med Sci. 1999;54A:M12-M16.
40. Hu J, El-Fakahany E. Allosteric interaction of dynorphin and myelin basic protein with muscarinic receptors. Pharmacology. 1993;47:351-359.
41. Hu J, Wang S, Forray C, El-Fakahany E. Complex allosteric interaction of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. Mol Pharmacol. 1992;42:311-324.
42. Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA. 1994;272:1518-1522.
43. Ratcheson R, Blank A, Ferendilli J. Regionally selective metabolic effects of hypoglycemia in the brain. J Neurochem. 1981;36:1952-1958.
44. Smythies JR, Gottfries C, Regland B. Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review. Biol Psychiatr. 1997;41:230-233.
45. van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Roest FHJ. Delirium after cardiac surgery: the possible role of tryptophan in relation to other neutral amino acids. In: Filippini GA, ed. Recent Advances in Tryptophan Research. New York: Plenum Press; 1996:93-96.
46. Trzepacz PT, Ho V, Mallavarapu H. Cholinergic delirium and neurotoxicity associated with tacrine for alzheimer's disease. Psychosomatics. 1996;37:299-301.
47. Imperato A, Dazzi L, Carta G, Colombo G, Biggio G. Rapid increase in basal acetylcholine release in the hippocampus of freely moving rats induced by withdrawal from long-term ethanol intoxication. Brain Res. 1998;347-350.
48. Kelly J. Cranial nerve nuclei, the reticular formation, and biogenic amine-containing neurons. In: Kandel E, Schwartz J, eds. Principles of Neural Science. New York: Elsevier; 1985:539-561.
49. Denoble V, Schrack L, Reigel A, Denoble K. Visual recognition in squirrel monkeys: effects of serotonin antagonists on baseline and hypoxia induced performance deficits. Pharmacol Biochem Behav. 1991;39:1991-1996.
50. Pope HG, Jonas JM, Hudson JI, Kafka MP. Toxic reactions to the combination of monoamine ocidase inhibitors and tryptophan. Am J Psychiatr. 1985;142:491-492.
51. Steiner W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatr. 1986;21:1067-1071.
52. Feighner JP, Boyer WF, Tyler DL, Neborsky RJ. Adverse consequences of fluoxetine-MAOI combination therapy. J Clin Psychiatr. 1990;51:222-225.
53. Sternbach H. The serotonin syndrome. Am J Psychiatr. 1991;148:705-713.
54. Gerson S, Baldessarini R. Motor effects of serotonin in the central nervous system. Life Sci. 1980;27:1435-1451.
55. Koponen H, Leopola U, Leinonen E. A long-term follow-up study of cerebrospinal fluid 5-hydroxyindolacetic acid in delirium. Eur Arch Psychiatry Clin Neurosci. 1994;244:131-134.
56. Banki J, Vojnik M. Comparative simultaneous measurement of cerebrospinal fluid 5-hydroxyindolacetic acid and blood serotonin levels in delirium tremens and clozapine-induced delirious reaction. J Neurol Neurosurg Psychiatr. 1978;41:420-424.
57. van der Mast RC, Fekkes D, Moleman P, Pepplinkhuizen L. Is postoperative delirium related to reduced plasma tryptophan? Lancet. 1991;338:851-852.
58. Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev. 1981;32:315-335.
59. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiologic regulation by plasma neutral amino acids. Science. 1972;178:414-416.
60. Milakofsky L, Hare TA, Miller JM. Rat plasma level of amino acids and related compounds during stress. Life Sci. 1985;36:753-761.
61. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet. 1997;349:915-919.
62. Hebenstreit GF, Fellerer GF, Twerdy B, Pfeiffer KP, Zadravec S, Ferdinand P. L-tryptophan bei pradeliranten und delianten zustandsbildern. Infusionstherapie. 1989;16:92-96.
63. Guttler F, Lou H. Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function. J Inher Metab Dis. 1986;9 (Suppl 2):169-177.
64. Krause W, Halminski M, Dembure P, Salvo R, Freides D, Elsas L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J Clin Invest. 1985;75:40-48.
65. Krause W, Epstein C, Averbook A, Dembure P, Elsas L. Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-dopa in treated patients with phenylketonuria. Pediatr Res. 1986;20:1112-1116.
66. Kaufman S. An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J Ped. 1989;114:895-900.
67. Takezawa J, Taenaka N, Nishijima MK, et al. Amino acids and thiobabituric acid reactive substances in cerebrospinal fluid and plasma of patients with septic encephalopathy. Crit Care Med. 1983;11:876-879.
68. Mizok B. Branched-chain amino acids in sepsis and hepatic failure. Arch Intern Med. 1985;145:1284-1288.
69. Cascino A, Cangiano C, Fiaccadori F, et al. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig Dis Sci. 1982;27:828-832.
70. Birkmayer W. Toxic delirium after L-dopa medication. J Neural Transm. 1978;14(Supp):163-166.
71. Cummings J. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc. 1991;39:708-716.
72. Golden RN, James SP, Sherer MA, Rudorfer MV, Sack DA, Potter WZ. Psychoses associated with buproprion treatment. Am J Psychiatr. 1985;142:1459-1462.
73. Pycock CJ, Carter CJ, Kerwin, RW. Effect of 6-hydroxy-dopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem. 1980;34:91-99.
74. Kramer TAM, Merriam A, Harvey P, Lisoskie MD. Acquired brain lesions and psychiatric illness: possible role of dopaminergic systems. Mt Sinai J Med. 1991;58:324-327.
75. Λ) receptor complex and hepatic encephalopathy. Ann Intern Med. 1989;110:532-546.
76. Basile A, Jones A, Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for involvement of benzodiazepine receptor ligands. Pharmacol Rev. 1991;43:27-71.
77. Unseld E, Ziegler G, Gemeinhar A, Janssen U, Klotz U. Possible interaction of fluroquinilones wih the benzodiazepine-GABAΛ-receptor complex. Br J Clin Pharmacol. 1990;30:63-70.
78. Farrington J, Stoudmire A, Tierney J. The role of ciprofloxacin in a patient with delirium due to multiple etiologies. Gen Hosp Psychiatry. 1995;17:47-53.
79. Ross CA. CNS arousal systems: possible role in delirium. Int Psychogeriatr. 1991;3:353-371.
80. Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 1990;16:426-432.
81. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Med. 1994;206:329-344.
82. Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Ann Rev Med. 1998;49:173-184.
83. Sara S. Noradrenergic modulation of selective attention: its role in memory retrieval. Ann NY Acad Sci. 1985;444:178-193.
84. McCann UD, Penetar DM, Shaham Y, et al. Sleep deprivation and impaired cognition: possible role of brain catecholamines. Biol Psychiatr. 1992;31:1082-1097.
85. Siejsjo B. Brain energy metaboplism and catecholaminergic activity in hypoxia, hypecapnia, and ischemia. J Neural Transm. 1978;14(Supp):17-22.
86. Giocobini E, Izikowitz S, Wegmann A. Norepinephrine and epinephrine excretion in delirium tremens. Arch Gen Psychiatr. 1960;3:289-296.
87. Ackenheil M, Athen D, Beckmann H. Pathophysiology of delirious states. J Neural Transm. 1978;14(Supp):167-175.
88. 2 blocker delirium. Psychosomatics. 1995;36:74-76.
89. Mogelnicki SR, Walter JL, Finlayson DC. Physostigmine reversal of cimetidine-induced mental confusion. JAMA. 1979;241:826-827.
90. Goff DC, Garber HJ, Jenike MA. Partial resolution of ranitidine-associated delirium with physostigmine: case report. J Clin Psychiatr. 1985;46:400-401.
91. Koponen H, Reinihainen K, Reikkinen P. Cerebrospinal fluid somatostatin in delirium II. Changes at the acute stage and at one year follow-up. Psychol Med. 1990;20:501-505.
92. Koponen H, Leinonen E. Lepola U, Reikkinen P. A long-term follow-up study of cerebrospinal fluid somatostatin in delirium. Acta Psychiatry Scand. 1984;89:178-193.
93. McIntosh TK, Bush H.L, Yetson NS, et al. Beta-endorphin, cortisol, and postoperative delirium: a preliminary report. Psychoneuroendocrinology. 1985;10:303-313.
94. Pickar D, Dubois M, Cohen MR. Behavioral change in a cancer patient following intrathecal beta endorphin administration. Am J Psychiatr. 1984;141:103-104.
95. Koponen H, Reikkinen P. A longitudinal study of cerebrospinal fluid betaendorphin-like immunoreactivity in delirium: chages at acute stage and one-year follow-up. Acta Psychiatr Scand. 1990;82:323-326.
96. Kiraly SJ, Ancill RJ, Dimitrovsa G. The relationship of endogenous cortisol to psychiatric disorder: a review. Can J Psychiatr. 1997;42:415-420.
97. DeKloet E, Veldhuis H. Adrenocortical hormone action. Handbook Neurochem. 1985;8:47-91.
98. Uno H, Eisele S, Sakai A, et al. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 1994;28:336-348.
99. van der Lely A, Foeken K, van der Mast RC, Lamberts SWJ. Rapid reversal of acute psychosis in the cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Intern Med. 1991;114:143-144.
100. Koponen H, Steinback U, Riekkinen PJ. Delrium and the DST in the aged. Nord Psykiatr Tidsskr. 1987;43:203-207.
101. McKieth IG. Clinical use of the DST in a psychogeriatric population. Br J Psychiatr. 1984;145:389-393.
102. O'Keeffe ST, Devline JG. Delirium and the dexamethasone supression test in the elderly. Neuropsychobiology. 1994;30:153-156.
103. Miller AH, Sastry G, Speranza AJ, et al. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatr. 1994;151:267-270.
104. Gustafson Y, Olsson T, Asplund K, Hagg E. Acute confusional state (delirium) soon after stroke is associated with hyperscortisolism. Cerebrovasc Dis. 1993;3:33-38.
105. Rosenberg S, Loetz M, Yang J. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg. 1989;210:474-484.
106. Denicoff K, Rubinow DR, Papa MZ, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphocyte-activated killer cells. Ann Intern Med. 1987;107:293-300.
107. Fenner M, Hanninen E, Kirchner H, Poliwoda H, Atzpodien J. Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-alpha [Letter]. Lancet. 1993;341:372.
108. Goodin D, Starr A, Chippendale T, Squires K. Sequential changes in the P3 componant of the auditory evoked potential in confusional states and dementing illness. Neurology. 1983;1215-1218.
109. Hammond E, Meador K, Aung-din R, Wilder B. Cholinergic modulation of human P3 event-related potentials. Neurology. 1987;37:346-350.
110. Caraceni A, Martini C, Belli F, et al. Neuropsychological assessment of the central effects of interleukin-2 administration. Eur J Cancer. 1992;29A:1266-1269.
111. Saris SC, Patronas NJ, Rosenberg SA, et al. The effect of interleukin-2 on brain water content. J Neurosurg. 1989;71:169-174.
112. Tearo A, Matssamura H, Saito M. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. J Neurosci. 1998;18:6599-6607.
113. 2. J Lipid Med Cell Signal. 1996;14:71-82.
114. Evans P. Free radicals in brain metabolism and pathology. Br Med Bull. 1993;49:577-587.
115. Jeppson B, Freund H, Gimmon Z, James J, von Mayenfeldt M, Fischer J. Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am J Surg. 1981;141:136-142.
116. Crossen J, Goldman D, Neuweldt E. Neuropsychological assessment of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery. 1991;30:23-29.
117. Knudsen G, Schmidt J, Almdal T, Paulson O, Vilstrup H. Passage of amino acids and glucose across the blood brian barrier in patients with hepatic encephalopathy. Hepatology. 1993;17:987-992.
118. Engel GL, Romano J. Delirium: a syndrome of cerebral insufficiency. J Chron Dis. 1959;9:260-277.
119. Blass JP, Plum F. Metabolic encephalopathies in older adults. In: Katzman R, Terry RD, eds. The Neurology of Aging. Philadelphia: FA Davis; 1983:189-220.
120. Geshwind N. Disorders of attention. Philos Trans R Soc Land Biol. 1982;298:173-185.
121. Benbadis SR, Sila CA, Cristea RL. Mental status changes and stroke. J Gen Intern Med. 1994;9:485-497.
122. Mach JR, Kabat V, Olsen D, Kuzkowski M. Delirium and right hemisphere dysfunction in cognitively impaired older persons. Int Psychogeriatr. 1996;8:373-382.
123. Trzepacz PT, Sclabassi RJ, van Thiel DM. Delirium: a subcortical phenomenon? J Neuropsychiatr. 1989;1:283-290.
124. Trzepacz PT. The neuropathogenesis of delirium: a need to focus our research. Psychosomatics. 1994;35:374-391.
125. Jacobson SA. Delirium in the elderly. Psych Clin North Am. 1997;20:91-110.
126. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47;1113-1124.
127. Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotropic activities in lewy body dementia: similarity to Parkinson's and distribution from Alzheimer's disease. Alz Dis Assoc Dis. 1993;7:69-79.
128. Perry EK, Marshall E, Kerwin JM, et al. Evidence of a monaminergic: cholinergic imbalance related to visual hallucinations in lewy body dementia. J Neurochem. 1990;55:1454-1456.